Publication Year 1997

Davenport, M. P., A. Godkin, T. Friede, S. Stevanovic, A. C. Willis, A. V. S. Hill, and H. G. Rammensee. 1997. A distinctive peptide binding motif for HLA-DRB1*0407, an HLA-DR4 subtype not associated with rheumatoid arthritis. Immunogenetics

Lammert, E., S. Stefanovic, J. Brunner, H. G. Rammensee, and H. J. Schild. 1997. Protein disulfide isomerase is the dominant acceptor for peptides translocated into the endoplasmic reticulum. Eur. J. Immunol. in press:

Munz, C., N. Holmes, A. King, Y. W. Loke, M. Colonna, H. Schild, and H. G. Rammensee. 1997. Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells. J. Exp. Med.

Reizis, B., H. Schild, S. Stefanovic, F. Mor, H. Rammensee, and I. R. Cohen. 1997. Peptide binding motifs of the MHC class I molecules (RT1.Al) of the Lewis rat. Immunogenetics

Undlien, D. E., T. Friede, H. G. Rammensee, G. Joner, K. Dahl Jorgensen, O. Sovik, H. E. Akselsen, I. Knutsen, K. S. Ronningen, and E. Thorsby. 1997. HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection. Diabetes

Last changed May 30, 1997. This page is being maintained by H.-G. and S. Rammensee. Feedback(rammensee@uni-tuebingen.de) is always welcome.